Oral drug as effective as IV chemotherapy

The Pharmaceutical Journal Group

首页> 外文期刊>The pharmaceutical journal >Oral drug as effective as IV chemotherapy

【24h】

Oral drug as effective as IV chemotherapy

机译：口服药物与静脉化疗一样有效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AstraZeneca's anticancer drug gefitinib (Iressa) is as effective as intravenous chemotherapy (docetaxel) at improving overall survival in non-small-cell lung cancer (NSCLC) patients, phase III trial results show (Lancet 2008;372:1809).

机译：III期试验结果显示，阿斯利康的抗癌药物吉非替尼（Iressa）在改善非小细胞肺癌（NSCLC）患者的总生存率方面与静脉化疗（多西他赛）一样有效（Lancet 2008; 372：1809）。

著录项

来源
《The pharmaceutical journal》 |2008年第7530期|共1页
作者
The Pharmaceutical Journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Oral drug as effective as IV chemotherapy [J] . The Pharmaceutical Journal Group The pharmaceutical journal . 2008,第7530期

机译：口服药物与静脉化疗一样有效
2. Oral chemotherapy drugs: new pharmaceutical needs for patients? Implementation of oral chemotherapy pharmaceutical consultation. Preliminary results in a French non-teaching hospital [J] . Gerardin Eric, Berod Thierry, Martinez Sylvie International journal of clinical pharmacy. . 2018,第1期

机译：口腔化疗药物：患者的新药物需求？口服化疗药物咨询的实施。法国非教学医院的初步结果
3. Efficacy of intravenous (IV) NEPA and oral NEPA, fixed NK1/5-HT3 receptor antagonist (RA) combination agents, for prevention of chemotherapy-induced nausea and vomiting (CINV) following anthracycline-cyclophosphamide (AC)-based chemotherapy [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：静脉注射（IV）NEPA和口服NEPA的功效，固定NK1 / 5-HT3受体拮抗剂（RA）组合剂，用于预防蒽环类环磷酰胺（AC）的化疗后的化疗诱导的恶性和呕吐（CINV）
4. Oral Administration of Eudragit Coated Bromelain Encapsulated PLGA Nanoparticles for Effective Delivery of Bromelain for Chemotherapy in vivo [C] . Bhatnagar Priyanka, Gupta Kailash Chand Southern Biomedical Engineering Conference . 2013

机译：Eudragit涂层菠萝蛋白酶封装的PLGA纳米颗粒的口服给药可有效递送菠萝蛋白酶进行体内化学疗法。
5. Oral care intervention to alleviate chemotherapy-induced oral mucositis in children with cancer. [D] . Cheng, Kin Fong. 2002

机译：口腔护理干预措施可减轻癌症儿童化疗引起的口腔粘膜炎。
6. Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC) [O] . Meinolf Karthaus, Csőszi Tibor, Vito Lorusso, -1

机译：口服帕洛诺司琼与IV帕洛诺司琼与地塞米松联合使用在预防以顺铂为基础的高致癌性化疗（HEC）实体瘤患者中预防化疗引起的恶心和呕吐（CINV）的疗效和安全性
7. PCNII COST-EFFECTIVENESS OF ORAL IBANDRONATE VERSUS IV ZOLEDRONIC ACID OR IV PAMIDRONATE IN THE TREATMENT OF BREAST CANCERWITH BONE METASTASES IN PATIENTS UNDERGOING IV CHEMOTHERAPY IN THE UK [O] . De Cock E, Hutton J, Barrett-Lee P, 2004

机译：在英国进行静脉化疗的患者中，口服异戊二酸相对于IV齐多酸或IV氨甲蝶呤的PCN成本效益

Oral drug as effective as IV chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅